Endoscopic lithotripsy combined with drug lithotripsy vs. drug lithotripsy for the treatment of phytobezoars: analysis of 165 cases
Surgical Endoscopy · 2024
DOI: 10.1007/s00464-024-10741-x ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Surgical Endoscopy, 2024. Verfasst von Xiao Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Peking University Shougang Hospital, Jinyuanzhuang 9 Road, Shijingshan District, Beijing, 100041, China. Hauptthemen laut MEDLINE: Bezoars, Lithotripsy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
AIM: To analyze efficacy of endoscopic lithotripsy combined with drug lithotripsy as compared with drug lithotripsy for the treatment of phytobezoars. METHODS: We collected and evaluated case records of 165 patients with phytobezoars from 2014 to 2023. And we analyzed demographic and clinical characteristics, imaging features, endoscopic features, complications of phytobezoars, and compared efficacy between endoscopic lithotripsy combined with drug lithotripsy (Group A) and drug lithotripsy (sodium bicarbonate combined with proton pump inhibitor) (Group B). RESULTS: The median age of patients with phytobezoars was 67.84 ± 4.286 years old. Abdominal pain was the most common symptom and peptic ulcers (67.5%) were the most common complication. Bezoar-induced ulcers were more frequent in the gastric angle. The success rate of phytobezoars vanishing in Group A and Group B were similar (92.3% vs. 85.1% within 48 h, 98.7% vs. 97.7% within a week), while the average hospitalization period, average hospitalization cost, second endoscopy rate, and average endoscopic operation time were significantly lower in patients in Group B than in Group A. CONCLUSION: Drug lithotripsy is the preferred effective and safe treatment option for phytobezoars. We advise that an endoscopy should be completed after 48 h for drug lithotripsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Peking University Shougang Hospital, Jinyuanzhuang 9 Road, Shijingshan District, Beijing, 100041, China.
- Department of Oncology, Peking University Third Hospital, Beijing, 100191, China.
- Department of Gastroenterology, Peking University Shougang Hospital, Jinyuanzhuang 9 Road, Shijingshan District, Beijing, 100041, China. 13910887208@163.com.
ORCID-Profile: Xiao-Wei Jin
Zitieren
APA
Zheng, X., Qiu, B., Jin, X. W., Liu, L. N., Wang, P., Yu, H. J., Zhang, J., Geng, W. J., Wang, R., & Liu, H. (2024). Endoscopic lithotripsy combined with drug lithotripsy vs. drug lithotripsy for the treatment of phytobezoars: analysis of 165 cases. Surgical Endoscopy. https://doi.org/10.1007/s00464-024-10741-x
Vancouver
Zheng X, Qiu B, Jin XW, Liu LN, Wang P, Yu HJ, et al. Endoscopic lithotripsy combined with drug lithotripsy vs. drug lithotripsy for the treatment of phytobezoars: analysis of 165 cases. Surgical Endoscopy. 2024. doi:10.1007/s00464-024-10741-x
BibTeX
@article{Zheng2024,
author = {Zheng, Xiao and Qiu, Bin and Jin, Xiao-Wei and Liu, Lin-Na and Wang, Peng and Yu, Hai-Jing and Zhang, Juan and Geng, Wen-Jing and Wang, Rui and Liu, Hua},
title = {Endoscopic lithotripsy combined with drug lithotripsy vs. drug lithotripsy for the treatment of phytobezoars: analysis of 165 cases},
journal = {Surgical Endoscopy},
year = {2024},
doi = {10.1007/s00464-024-10741-x}
}
EUVIMED